What it is used for

HARVONI (ledipasvir/sofosbuvir fixed-dose combination) is indicated for the treatment of chronic hepatitis C (CHC) infection in adults. (see PRECAUTIONS and CLINICAL TRIALS sections for information on the available data for HCV patients of each genotype, see DOSAGE AND ADMINISTRATION section for recommended regimens and treatment durations for different patient subgroups).

How to take it

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

• The way to take this medicine: Oral
• Store below 30 degrees Celsius
• Store at room temperature
• Lifetime is 48 Months.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Film coated, orange, diamond shaped tablet with "GSI" on one side and "7985" on the other side

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.

Is this medicine subsidised?

This medicine is subsidised which may make it cheaper. To learn more about this subsidy, visit the Phamaceutical Benefits Scheme (PBS) website

Pregnant or planning a pregnancy?

For the active ingredient ledipasvir + sofosbuvir

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.